WITHDRAWN: Characterization of Patterns of Immune Cell Infiltration in NSCLC.

Autor: Backman M; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden., La Fleur L; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden., Kurppa P; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden., Djureinovic D; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden., Elfving H; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden., Brunnström H; Division of Oncology and Pathology, Department of Clinical Sciences, Lund University, Lund, Sweden., Mattsson JSM; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden., Pontén V; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden., Eltahir M; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden; Department of Pharmaceutical Bioscience, Uppsala University, Uppsala, Sweden., Mangsbo S; Department of Pharmaceutical Bioscience, Uppsala University, Uppsala, Sweden., Isaksson J; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden; Department of Respiratory Medicine, Gävle Hospital, Gävle, Sweden., Jirström K; Division of Oncology and Pathology, Department of Clinical Sciences, Lund University, Lund, Sweden., Kärre K; Department of Microbiology, Cell and Tumor Biology, Karolinska Institute, Stockholm, Sweden., Carbone E; Department of Microbiology, Cell and Tumor Biology, Karolinska Institute, Stockholm, Sweden; Department of Experimental and Clinical Medicine, Tumor Immunology and Immunopathology Laboratory, University Magna Graecia of Catanzaro, Catanzaro, Italy., Leandersson K; Department of Translational Medicine, Cancer Immunology, Lund University, Skåne University Hospital, Malmö, Sweden., Mezheyeuski A; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden., Pontén F; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden., Lindskog C; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden., Botling J; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden., Micke P; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.

Publikováno v: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer [J Thorac Oncol] 2020 Feb 04. Date of Electronic Publication: 2020 Feb 04.

NK- and T-cell subsets in malignant mesothelioma patients: Baseline pattern and changes in the context of anti-CTLA-4 therapy.

Autor: Sottile R; Department of Microbiology, Tumor and Cell Biology (MTC), Karolinska Institutet, Stockholm, Sweden., Tannazi M; Department of Pharmaceutical Science, Faculty of Science, Utrecht University, Utrecht, Netherlands., Johansson MH; Department of Microbiology, Tumor and Cell Biology (MTC), Karolinska Institutet, Stockholm, Sweden., Cristiani CM; Tumor Immunology and Immunopathology Laboratory, Department of Experimental and Clinical Medicine, University Magna Graecia of Catanzaro, Catanzaro, Italy., Calabró L; Center for Immuno-Oncology, Medical Oncology and Immunotherapy, University Hospital of Siena, Siena, Italy., Ventura V; Tumor Immunology and Immunopathology Laboratory, Department of Experimental and Clinical Medicine, University Magna Graecia of Catanzaro, Catanzaro, Italy., Cutaia O; Center for Immuno-Oncology, Medical Oncology and Immunotherapy, University Hospital of Siena, Siena, Italy., Chiarucci C; Center for Immuno-Oncology, Medical Oncology and Immunotherapy, University Hospital of Siena, Siena, Italy., Covre A; Center for Immuno-Oncology, Medical Oncology and Immunotherapy, University Hospital of Siena, Siena, Italy., Garofalo C; Tumor Immunology and Immunopathology Laboratory, Department of Experimental and Clinical Medicine, University Magna Graecia of Catanzaro, Catanzaro, Italy., Pontén V; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala University Hospital, Uppsala, Sweden., Tallerico R; Tumor Immunology and Immunopathology Laboratory, Department of Experimental and Clinical Medicine, University Magna Graecia of Catanzaro, Catanzaro, Italy., Frumento P; Institute of Environmental Medicine, Unit of Biostatistics, Karolinska Institutet, Stockholm, Sweden., Micke P; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala University Hospital, Uppsala, Sweden., Maio M; Center for Immuno-Oncology, Medical Oncology and Immunotherapy, University Hospital of Siena, Siena, Italy., Kärre K; Department of Microbiology, Tumor and Cell Biology (MTC), Karolinska Institutet, Stockholm, Sweden., Carbone E; Department of Microbiology, Tumor and Cell Biology (MTC), Karolinska Institutet, Stockholm, Sweden.; Tumor Immunology and Immunopathology Laboratory, Department of Experimental and Clinical Medicine, University Magna Graecia of Catanzaro, Catanzaro, Italy.

Publikováno v: International journal of cancer [Int J Cancer] 2019 Oct 15; Vol. 145 (8), pp. 2238-2248. Date of Electronic Publication: 2019 May 13.

P2.02-066 Identification of Crucial Gene Targets in the in Situ Environment of Cancer by Google Network Ranking

Autor: Pontén, V., Backman, M., Mattsson, J., Djureinovic, D., Micke, P.

Publikováno v: In Journal of Thoracic Oncology November 2017 12(11) Supplement 2:S2124-S2124

Expression of scavenger receptor MARCO defines a targetable tumor-associated macrophage subset in non-small cell lung cancer.

Autor: La Fleur L; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Department of Pathology, Uppsala University Hospital, Uppsala, Sweden., Boura VF; Department of Microbiology, Tumor and Cell biology, Karolinska institutet, Stockholm, Sweden., Alexeyenko A; Department of Microbiology, Tumor and Cell biology, Karolinska institutet, Stockholm, Sweden.; Science for Life Laboratory, National Bioinformatics Infrastructure Sweden, Solna, Sweden., Berglund A; Epistat, Uppsala, Sweden., Pontén V; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Department of Pathology, Uppsala University Hospital, Uppsala, Sweden., Mattsson JSM; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Department of Pathology, Uppsala University Hospital, Uppsala, Sweden., Djureinovic D; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Department of Pathology, Uppsala University Hospital, Uppsala, Sweden., Persson J; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Department of Pathology, Uppsala University Hospital, Uppsala, Sweden., Brunnström H; Division of Pathology, Lund University, Skåne University Hospital, Lund, Sweden., Isaksson J; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Department of Pathology, Uppsala University Hospital, Uppsala, Sweden.; Department of Respiratory Medicine, Gävle Hospital, Gävle, Sweden.; County Council of Gävleborg, Centre for Research and Development, Uppsala University, Uppsala, Sweden., Brandén E; Department of Respiratory Medicine, Gävle Hospital, Gävle, Sweden.; County Council of Gävleborg, Centre for Research and Development, Uppsala University, Uppsala, Sweden., Koyi H; Department of Respiratory Medicine, Gävle Hospital, Gävle, Sweden.; County Council of Gävleborg, Centre for Research and Development, Uppsala University, Uppsala, Sweden., Micke P; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Department of Pathology, Uppsala University Hospital, Uppsala, Sweden., Karlsson MCI; Department of Microbiology, Tumor and Cell biology, Karolinska institutet, Stockholm, Sweden., Botling J; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Department of Pathology, Uppsala University Hospital, Uppsala, Sweden.

Publikováno v: International journal of cancer [Int J Cancer] 2018 Oct 01; Vol. 143 (7), pp. 1741-1752. Date of Electronic Publication: 2018 May 13.

In Silico Transcriptomic Expression of MSR1 in Solid Tumors Is Associated with Responses to Anti-PD1 and Anti-CTLA4 Therapies.

Autor: Sanvicente, Adrián^1,2 (AUTHOR) adrian.sanvicente@salud.madrid.org, Díaz-Tejeiro, Cristina¹ (AUTHOR) cristina.diaztejeiro@salud.madrid.org, Nieto-Jiménez, Cristina¹ (AUTHOR) cnjietoj@salud.madrid.org, Paniagua-Herranz, Lucia¹ (AUTHOR) lucia.paniagua@salud.madrid.org, López Cade, Igor^1,3 (AUTHOR) ilopez.7@alumni.unav.es, Balázs, Győrffy^4,5 (AUTHOR) gyorffy.balazs@yahoo.com, Moreno, Víctor⁶ (AUTHOR) victor.moreno@startmadrid.com, Pérez-Segura, Pedro⁷ (AUTHOR) pedro.perez@salud.madrid.org, Calvo, Emiliano^6,8 (AUTHOR) emiliano.calvo@startmadrid.com, Ocaña, Alberto^1,7,9 (AUTHOR) alberto.ocana@salud.madrid.org

Publikováno v: International Journal of Molecular Sciences. Apr2024, Vol. 25 Issue 7, p3987. 13p.